Our purpose , within the @-month phase @ TRANSFORMS study , was to examine the effect of treatment on BV loss in patient subgroups , establish correlations between baseline normalized BV ( NBV ) and baseline disease parameters , to identify variables predictive of baseline NBV and on-study percentage BV change ( PBVC ) , and to establish correlations between on-study PBVC and on-study efficacy outcomes .